A medical technology company in Australia is aiming for a world-first: it wants to launch a blood test for endometriosis (sometimes called ‘endo’ for short) within the first half of this year.
In a recent peer-reviewed trial, its novel test proved 99.7 percent accurate at distinguishing severe cases of endometriosis from patients without the disease but with similar symptoms.
Even in the early stages of the disease, when blood markers may be harder to pick out, the test’s accuracy remained over 85 percent.
